Detection and Management of Intraocular Inflammation after Brolucizumab Treatment for Neovascular Age-Related Macular Degeneration

被引:0
|
作者
Bodaghi, Bahram
Souied, Eric H.
Tadayoni, Ramin
Weber, Michel
Ponthieux, Anne
Kodjikian, Laurent
机构
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:1106 / 1106
页数:1
相关论文
共 50 条
  • [21] Bilateral occlusive vasculitis after intravitreal injection of brolucizumab in neovascular age-related macular degeneration
    Riedel, Anna Maria
    Lackerbauer, Carlo
    Lohmann, Chris P.
    Ulbig, Michael
    OPHTHALMOLOGE, 2022, 119 (01): : 75 - 78
  • [22] Bilateral occlusive vasculitis after intravitreal injection of brolucizumab in neovascular age-related macular degeneration
    Riedel, Anna Maria
    Lackerbauer, Carlo
    Lohmann, Chris P.
    Ulbig, Michael
    OPHTHALMOLOGIE, 2022, 119 (01): : 75 - 78
  • [23] Changes in blood flow one year after treatment with aflibercept or brolucizumab for neovascular age-related macular degeneration
    Yamada, Takeyasu
    Osaka, Rie
    Akimitsu, Junichiro
    Kojima, Hirokazu
    Miyoshi, Yukiko
    Yamashita, Ayana
    Nakano, Yuki
    Suzuma, Kiyoshi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [24] INTRAOCULAR INFLAMMATION FOLLOWING INTRAVITREAL FARICIMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD)
    Punit, Ankita Abhinandan
    Hasan, Hani
    Da Costa, Joanna
    EYE, 2024, 38 : 173 - 173
  • [25] Brolucizumab for treating neovascular age-related macular degeneration: An alternative for treatment-refractory patients
    Groen, Martin Biilmann
    Vestergaard, Anders Hojslet
    Cehofski, Lasse Jorgensen
    ACTA OPHTHALMOLOGICA, 2025,
  • [26] Intravitreal brolucizumab in neovascular age-related macular degeneration with limited response to aflibercept
    Hatz, Katja B.
    Cedro, Luca
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [27] Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
    Ashish Sharma
    Nilesh Kumar
    Nikulaa Parachuri
    Rohini Sharma
    Francesco Bandello
    Baruch D. Kuppermann
    Carl D. Regillo
    Eye, 2020, 34 : 1310 - 1312
  • [28] Efficacy of switching to brolucizumab for neovascular age-related macular degeneration refractory to faricimab
    Hoshino, Junki
    Matsumoto, Hidetaka
    Nakamura, Kosuke
    Akiyama, Hideo
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2025, : 221 - 229
  • [29] Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
    Sharma, Ashish
    Kumar, Nilesh
    Parachuri, Nikulaa
    Sharma, Rohini
    Bandello, Francesco
    Kuppermann, Baruch D.
    Regillo, Carl D.
    EYE, 2020, 34 (08) : 1310 - 1312
  • [30] Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration
    Quan Dong Nguyen
    Das, Arup
    Do, Diana, V
    Dugel, Pravin U.
    Gomes, Andre
    Holz, Frank G.
    Koh, Adrian
    Pan, Carolyn K.
    Sepah, Yasir J.
    Patel, Nikhil
    MacLeod, Heather
    Maurer, Patrik
    OPHTHALMOLOGY, 2020, 127 (07) : 963 - 976